For the quarter ending 2026-03-31, VVOS has $25,043K in assets. $26,310K in debts. $2,110K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 2,110 | 2,029 | 3,087 | 4,402 |
| Accounts receivable, net of allowance of 1,159 and 882, respectively | 1,769 | 1,581 | 2,134 | 1,633 |
| Prepaid expenses and other current assets | 940 | 774 | 565 | 695 |
| Total current assets | 4,819 | 4,384 | 5,786 | 6,730 |
| Goodwill | 8,572 | 8,572 | 8,450 | 8,450 |
| Gross property and equipment | 6,710 | 6,693 | 8,673 | - |
| Less accumulated depreciation | 3,184 | 2,936 | 3,031 | - |
| Property and equipment, net | 3,526 | 3,757 | 5,642 | 5,129 |
| Operating lease right-of-use asset | 4,033 | 4,166 | 3,383 | 3,244 |
| Intangible assets, net | 3,839 | 4,045 | 2,172 | 2,225 |
| Deposits and other | 254 | 228 | 211 | 255 |
| Total assets | 25,043 | 25,152 | 25,644 | 26,033 |
| Accounts payable | 1,996 | 1,679 | 2,103 | 1,763 |
| Accrued expenses | 6,113 | 5,988 | 2,682 | 2,302 |
| Current portion of contract liabilities | 495 | 479 | 537 | 480 |
| Current portion of operating lease liability | 744 | 672 | 734 | 654 |
| Current portion of financing lease liability | 56 | 55 | 55 | 55 |
| Current portion of debt | 7,299 | 8,353 | 339 | 157 |
| Other current liabilities | 1,234 | 850 | 987 | 1,015 |
| Total current liabilities | 17,937 | 18,076 | 7,437 | 6,426 |
| Contract liabilities, net of current portion | - | - | 1 | 5 |
| Employee retention credit liability | 2,904 | 2,904 | 2,904 | 2,904 |
| Operating lease liability, net of current portion | 3,653 | 3,840 | 2,866 | 2,814 |
| Financing lease liability, net of current portion | 98 | 113 | 125 | 141 |
| Debt, net of current portion | 418 | 469 | 8,379 | 7,760 |
| Other liabilities | 1,300 | 1,300 | 1,400 | 1,400 |
| Total liabilities | 26,310 | 26,702 | 23,112 | 21,450 |
| Common stock, 0.0001 par value per share. authorized 200,000,000 shares issued and outstanding 13,486,006 shares as of march 31, 2026 and 9,286,609 shares as december 31, 2025 | 1 | 1 | 1 | - |
| Additional paid-in capital | 131,900 | 123,866 | 120,995 | 117,647 |
| Accumulated deficit | -133,039 | -125,357 | -118,464 | -113,064 |
| Total stockholders equity/(deficit) | -1,138 | -1,490 | 2,532 | 4,583 |
| Non-controlling interest | -129 | -60 | - | - |
| Total equity/(deficit) | -1,267 | -1,550 | - | - |
| Total liabilities and equity/(deficit) | 25,043 | 25,152 | 25,644 | 26,033 |
Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. (VVOS)